• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于抗癌光动力疗法的免疫原性细胞死亡诱导型钌基光敏剂的发现。

Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy.

作者信息

Konda Prathyusha, Lifshits Liubov M, Roque John A, Cole Houston D, Cameron Colin G, McFarland Sherri A, Gujar Shashi

机构信息

Department of Microbiology and Immunology, Dalhousie University, Halifax, Canada.

Department of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, TX, USA.

出版信息

Oncoimmunology. 2020 Dec 29;10(1):1863626. doi: 10.1080/2162402X.2020.1863626.

DOI:10.1080/2162402X.2020.1863626
PMID:33457082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7781847/
Abstract

We report a new class of ruthenium (Ru)-based photosensitizers that induce potent cytotoxicity in melanoma cells following activation with NIR light. In addition to the direct cytotoxic effect, this Ru-based photodynamic therapy induces immunogenic cell death in melanoma cells that can be therapeutically exploited to establish protective antitumor immunity.

摘要

我们报告了一类新型的钌(Ru)基光敏剂,其在近红外光激活后可在黑色素瘤细胞中诱导强烈的细胞毒性。除了直接的细胞毒性作用外,这种基于钌的光动力疗法还可诱导黑色素瘤细胞发生免疫原性细胞死亡,这可被用于治疗以建立保护性抗肿瘤免疫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef0/7781847/1680382c91d9/KONI_A_1863626_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef0/7781847/1680382c91d9/KONI_A_1863626_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef0/7781847/1680382c91d9/KONI_A_1863626_F0001_OC.jpg

相似文献

1
Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy.用于抗癌光动力疗法的免疫原性细胞死亡诱导型钌基光敏剂的发现。
Oncoimmunology. 2020 Dec 29;10(1):1863626. doi: 10.1080/2162402X.2020.1863626.
2
Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.评估基于钌(II)的光敏剂的作用机制和亚细胞定位。
Eur J Med Chem. 2021 Dec 5;225:113770. doi: 10.1016/j.ejmech.2021.113770. Epub 2021 Aug 11.
3
Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.Ru(II) 金属卟啉配合物作为单光子和双光子光动力治疗光敏剂的应用的关键综述。
Acc Chem Res. 2017 Nov 21;50(11):2727-2736. doi: 10.1021/acs.accounts.7b00180. Epub 2017 Oct 23.
4
Strained ruthenium complexes are potent light-activated anticancer agents.负载钌的配合物是一种有效的光激活型抗癌试剂。
J Am Chem Soc. 2012 May 23;134(20):8324-7. doi: 10.1021/ja3009677. Epub 2012 May 11.
5
Photobiomodulation combined with photodynamic therapy using ruthenium phthalocyanine complexes in A375 melanoma cells: Effects of nitric oxide generation and ATP production.钌酞菁配合物的光动力学疗法联合光生物调节疗法对 A375 黑素瘤细胞的作用:一氧化氮生成和三磷酸腺苷产生的影响。
J Photochem Photobiol B. 2019 Sep;198:111564. doi: 10.1016/j.jphotobiol.2019.111564. Epub 2019 Jul 25.
6
Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.钌(II)配合物作为用于针对三阴性乳腺癌细胞的肿瘤特异性光动力疗法的生物正交双光子光敏剂。
Chem Commun (Camb). 2021 May 4;57(36):4408-4411. doi: 10.1039/d1cc00661d.
7
Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents.钌(II)多吡啶配合物作为线粒体靶向双光子光动力抗癌剂。
Biomaterials. 2015 Jul;56:140-53. doi: 10.1016/j.biomaterials.2015.04.002. Epub 2015 Apr 17.
8
A Half-Sandwich Ruthenium(II) (N^N) Complex: Inducing Immunogenic Melanoma Cell Death in Vitro and in Vivo.半夹心钌(II)(N^N)配合物:体外和体内诱导免疫原性黑色素瘤细胞死亡。
ChemMedChem. 2023 Aug 15;18(16):e202300131. doi: 10.1002/cmdc.202300131. Epub 2023 Jun 16.
9
Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights.钌(II)-芳基姜黄素配合物作为抗肿瘤和抗菌光动力治疗的光敏剂:体外和体内研究进展。
Molecules. 2023 Nov 11;28(22):7537. doi: 10.3390/molecules28227537.
10
Ru(II)-Cyanine Complexes as Promising Photodynamic Photosensitizers for the Treatment of Hypoxic Tumours with Highly Penetrating 770 nm Near-Infrared Light.Ru(II)-Cy​​anine 配合物作为有前途的光动力光敏剂,用于用高穿透力的 770nm 近红外光治疗缺氧肿瘤。
Chemistry. 2023 Nov 2;29(61):e202301742. doi: 10.1002/chem.202301742. Epub 2023 Sep 22.

引用本文的文献

1
Metal-based immunogenic cell death inducers for cancer immunotherapy.用于癌症免疫治疗的金属基免疫原性细胞死亡诱导剂。
Chem Sci. 2025 Feb 25;16(15):6160-6187. doi: 10.1039/d4sc08495k. eCollection 2025 Apr 9.
2
Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition autophagy-dependent ferroptosis.基于异喹啉生物碱的环金属化铱(III)配合物协同引发免疫原性细胞死亡反应并抑制吲哚胺2,3-双加氧酶依赖自噬的铁死亡。
Acta Pharm Sin B. 2025 Jan;15(1):424-437. doi: 10.1016/j.apsb.2024.06.017. Epub 2024 Jun 25.
3
Engineering of bespoke photosensitiser-microbe interfaces for enhanced semi-artificial photosynthesis.

本文引用的文献

1
Near-infrared absorbing Ru(ii) complexes act as immunoprotective photodynamic therapy (PDT) agents against aggressive melanoma.近红外吸收钌(II)配合物作为针对侵袭性黑色素瘤的免疫保护性光动力疗法(PDT)药物。
Chem Sci. 2020 Sep 9;11(43):11740-11762. doi: 10.1039/d0sc03875j. eCollection 2020 Nov 21.
2
Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions.免疫疗法治疗转移性黑色素瘤:现有知识和未来方向。
J Immunol Res. 2020 Jun 28;2020:9235638. doi: 10.1155/2020/9235638. eCollection 2020.
3
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
定制用于增强半人工光合作用的光敏剂-微生物界面的工程设计。
Chem Sci. 2024 May 21;15(26):9893-9914. doi: 10.1039/d4sc00864b. eCollection 2024 Jul 3.
4
Nanomolar concentrations of the photodynamic compound TLD-1433 effectively inactivate numerous human pathogenic viruses.纳摩尔浓度的光动力化合物TLD-1433能有效使多种人类致病病毒失活。
Heliyon. 2024 May 29;10(11):e32140. doi: 10.1016/j.heliyon.2024.e32140. eCollection 2024 Jun 15.
5
Cu(II) complex that synergistically potentiates cytotoxicity and an antitumor immune response by targeting cellular redox homeostasis.靶向细胞氧化还原稳态的 Cu(II) 配合物通过协同增强细胞毒性和抗肿瘤免疫反应。
Proc Natl Acad Sci U S A. 2024 Jun 11;121(24):e2404668121. doi: 10.1073/pnas.2404668121. Epub 2024 Jun 4.
6
Immuno-photodynamic Therapy (IPDT): Organic Photosensitizers and Their Application in Cancer Ablation.免疫光动力疗法(IPDT):有机光敏剂及其在癌症消融中的应用
JACS Au. 2023 Feb 14;3(3):682-699. doi: 10.1021/jacsau.2c00591. eCollection 2023 Mar 27.
7
A mitochondria-localized iridium(iii) photosensitizer for two-photon photodynamic immunotherapy against melanoma.一种用于双光子光动力免疫治疗黑色素瘤的线粒体定位铱(III)光敏剂。
Chem Sci. 2023 Jan 12;14(6):1461-1471. doi: 10.1039/d2sc06675k. eCollection 2023 Feb 8.
8
Ru(II) CONTAINING PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY: A CRITIQUE ON REPORTING AND AN ATTEMPT TO COMPARE EFFICACY.用于光动力疗法的含钌(II)光敏剂:关于报告的评论及疗效比较尝试
Coord Chem Rev. 2022 Nov 1;470. doi: 10.1016/j.ccr.2022.214712. Epub 2022 Jul 26.
9
Utilization of Cancer Cell Line Screening to Elucidate the Anticancer Activity and Biological Pathways Related to the Ruthenium-Based Therapeutic BOLD-100.利用癌细胞系筛选来阐明与钌基治疗药物BOLD-100相关的抗癌活性和生物学途径。
Cancers (Basel). 2022 Dec 21;15(1):28. doi: 10.3390/cancers15010028.
10
Establishing a Robust and Reliable Response from a Potent Osmium-Based Photosensitizer Via Lipid Nanoformulation.通过脂质纳米制剂建立一种有效的基于锇的光敏剂的强大且可靠的响应。
Photochem Photobiol. 2023 Mar;99(2):751-760. doi: 10.1111/php.13756. Epub 2022 Dec 25.
免疫原性细胞死亡的定义、检测及解读的共识指南。
J Immunother Cancer. 2020 Mar;8(1). doi: 10.1136/jitc-2019-000337.
4
Immunotherapy of Melanoma: Facts and Hopes.黑色素瘤的免疫治疗:现状与展望。
Clin Cancer Res. 2019 Sep 1;25(17):5191-5201. doi: 10.1158/1078-0432.CCR-18-1550. Epub 2019 Mar 28.
5
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.从肿瘤为中心的角度探讨过渡金属配合物和光动力疗法:TLD1433 开发中的挑战、机遇和亮点。
Chem Rev. 2019 Jan 23;119(2):797-828. doi: 10.1021/acs.chemrev.8b00211. Epub 2018 Oct 8.
6
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.癌症免疫疗法的疗效与患者性别:系统评价和荟萃分析。
Lancet Oncol. 2018 Jun;19(6):737-746. doi: 10.1016/S1470-2045(18)30261-4. Epub 2018 May 16.
7
Immunogenic cell death in cancer and infectious disease.肿瘤和传染病中的免疫原性细胞死亡
Nat Rev Immunol. 2017 Feb;17(2):97-111. doi: 10.1038/nri.2016.107. Epub 2016 Oct 17.
8
B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses.B7-H1 依赖性肿瘤免疫和免疫治疗反应的性别相关差异。
J Immunol. 2010 Sep 1;185(5):2747-53. doi: 10.4049/jimmunol.1000496. Epub 2010 Aug 4.
9
Role of cytokines in photodynamic therapy-induced local and systemic inflammation.细胞因子在光动力疗法诱导的局部和全身炎症中的作用。
Br J Cancer. 2003 Jun 2;88(11):1772-9. doi: 10.1038/sj.bjc.6600864.